Literature DB >> 26108877

[Intensive care therapy of space-occupying large hemispheric infarction. Summary of the NCS/DGNI guidelines].

J Bösel1, S Schönenberger, C Dohmen, E Jüttler, D Staykov, K Zweckberger, W Hacke, S Schwab, M T Torbey, H B Huttner.   

Abstract

Large hemispheric infarction (LHI), synonymously called malignant middle cerebral artery (MCA) infarction, is a severe neurological disease with a high mortality and morbidity. Treating physicians as well as relatives are often faced with few and low quality data when attempting to apply optimal treatment to these patients and make decisions. While current stroke treatment guidelines focus on risk factors, prevention and acute management, they include only limited recommendations concerning intensive care management of LHI. The Neurocritical Care Society (NCS) and the German Society for Neurocritical and Emergency Medicine (DGNI) organized an interdisciplinary consensus conference on intensive care management of LHI to meet this demand. European and American experts in neurology, neurocritical care, neurosurgery, neuroradiology and neuroanesthesiology were selected based on their expertise and research focus. Subgroups for several main topics elaborated a number of central clinical questions concerning this topic and evaluated the quality of the currently available data according to the grading of recommendation assessment, development and evaluation (GRADE) guideline system. Subsequently, evidence-based recommendations were compiled after weighing the advantages against the disadvantages of certain management options. This is a commented abridged version of the results of the consensus conference.

Entities:  

Mesh:

Year:  2015        PMID: 26108877     DOI: 10.1007/s00115-015-4361-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  26 in total

1.  Decompressive surgery in malignant infarction of the middle cerebral artery.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

2.  Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.

Authors:  Michel T Torbey; Julian Bösel; Denise H Rhoney; Fred Rincon; Dimitre Staykov; Arun P Amar; Panayiotis N Varelas; Eric Jüttler; DaiWai Olson; Hagen B Huttner; Klaus Zweckberger; Kevin N Sheth; Christian Dohmen; Ansgar M Brambrink; Stephan A Mayer; Osama O Zaidat; Werner Hacke; Stefan Schwab
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

3.  DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II.

Authors:  Eric Jüttler; Julian Bösel; Hemasse Amiri; Petra Schiller; Ronald Limprecht; Werner Hacke; Andreas Unterberg
Journal:  Int J Stroke       Date:  2011-02       Impact factor: 5.266

4.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

5.  Surgical aspects of decompression craniectomy in malignant stroke: review.

Authors:  Klaus Zweckberger; Eric Juettler; Julian Bösel; W Andreas Unterberg
Journal:  Cerebrovasc Dis       Date:  2014-11-21       Impact factor: 2.762

6.  Stroke-related Early Tracheostomy versus Prolonged Orotracheal Intubation in Neurocritical Care Trial (SETPOINT): a randomized pilot trial.

Authors:  Julian Bösel; Petra Schiller; Yvonne Hook; Michaela Andes; Jan-Oliver Neumann; Sven Poli; Hemasse Amiri; Silvia Schönenberger; Zhongying Peng; Andreas Unterberg; Werner Hacke; Thorsten Steiner
Journal:  Stroke       Date:  2012-11-29       Impact factor: 7.914

7.  Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial.

Authors:  Jeffrey I Frank; L Philip Schumm; Kristen Wroblewski; Douglas Chyatte; Axel J Rosengart; Christi Kordeck; Ronald A Thisted
Journal:  Stroke       Date:  2014-01-14       Impact factor: 7.914

8.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

Authors:  Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp
Journal:  Lancet Neurol       Date:  2009-03-05       Impact factor: 44.182

9.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk.

Authors:  R von Kummer; U Meyding-Lamadé; M Forsting; L Rosin; K Rieke; W Hacke; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1994-01       Impact factor: 3.825

10.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

View more
  6 in total

1.  [Intensive care studies from 2017/2018].

Authors:  C J Reuß; M Bernhard; C Beynon; A Hecker; C Jungk; C Nusshag; M A Weigand; D Michalski; T Brenner
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

2.  [Survey regarding the treatment of malignant middle cerebral artery infarction in German hospitals].

Authors:  H Neugebauer; S Wiedmann; E Jüttler
Journal:  Nervenarzt       Date:  2016-04       Impact factor: 1.214

Review 3.  Quality of stroke guidelines in low- and middle-income countries: a systematic review.

Authors:  Joseph Yaria; Artyom Gil; Akintomiwa Makanjuola; Richard Oguntoye; J Jaime Miranda; Maria Lazo-Porras; Puhong Zhang; Xuanchen Tao; Jhon Álvarez Ahlgren; Antonio Bernabe-Ortiz; Miguel Moscoso-Porras; German Malaga; Irina Svyato; Morenike Osundina; Camila Gianella; Olamide Bello; Abisola Lawal; Ajagbe Temitope; Oluwadamilola Adebayo; Monkol Lakkhanaloet; Michael Brainin; Walter Johnson; Amanda G Thrift; Jurairat Phromjai; Annabel S Mueller-Stierlin; Sigiriya Aebischer Perone; Cherian Varghese; Valery Feigin; Mayowa O Owolabi
Journal:  Bull World Health Organ       Date:  2021-06-29       Impact factor: 9.408

4.  [Focus neurological intensive care medicine 2021/2022 : Summary of selected intensive care studies].

Authors:  D Michalski; C Jungk; T Brenner; C Nusshag; C J Reuß; M O Fiedler; F C F Schmitt; M Bernhard; C Beynon; M A Weigand; M Dietrich
Journal:  Anaesthesiologie       Date:  2022-09-20

5.  Decompressive hemicraniectomy for malignant middle cerebral artery infarction. Experience from the Western Province of Saudi Arabia.

Authors:  Haifa M Algethamy; Afnan Samman; Saleh S Baeesa; Mohammed A Almekhlafi; Yousef A Al Said; Ahmed Hassan
Journal:  Neurosciences (Riyadh)       Date:  2017-07       Impact factor: 0.906

6.  Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction.

Authors:  You Yu; Lin Wang; Xu Zhu; Ya-Fei Liu; Hai-Ying Ma
Journal:  World J Diabetes       Date:  2021-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.